Course Director

• Vincent Grégoire, Radiation Oncologist, Centre Léon Bérard Lyon (FR)
• René Leemans, ORL/Head and Neck Surgeon, Amsterdam University Medical Centres, VU University (NL) 
• Lisa Licitra, Medical Oncologist, Istituto Tumori, Milan and University of Milan (IT)

Teachers

• Jesper Grau Eriksen, Clinical Oncologist, Arhus University Hospital (DK)
• Marco Ferrari, Oto-Rhino-Laryngologist and Head and Neck Surgeon, University of Padova (IT)
• Jean-Pascal Machiels, Medical Oncologist, Cliniques Universitaires St-Luc (BE)
• Piero Nicolai, Oto-Rhino-Laryngologist and Head and Neck Surgeon, University of Brescia (IT)
• Frank A. Pameijer, Radiologist, University Medical Center Utrecht (UMCU) (NL)

Local organiser

• Martin Doležel, Chairman of the SROBF,  Deputy Head of the Oncology Clinic for Radiation Oncology; Vice-Dean for Science and Research, Faculty of Medicine, University of Olomouc

The course aims to be interactive through integration of multidisciplinary lectures and more focused workshops. The faculty includes renowned European experts involved in the multidisciplinary treatment of head and neck cancer.

Learning outcomes

By the end of this course participants should be able to:

• Understand the evolving concepts of head and neck epidemiology and tumour biology, with special focus on squamous cell histotype. Rare histotypes will also be included
• Interpret complex head and neck imaging for the purpose of treatment decision making and therapy
• Make judgements regarding multidisciplinary reasoning and management of tumours in the light of alternative and sometimes competing treatment options, including surgery and the role of systemic and targeted therapies 
• Make judgments on the availability of evidence for treatment recommendations
• Understand the challenges of supportive care 
• Understand the principles and practice of modern radiotherapy

Course content

• Anatomy (clinical and radiologic aspects) incidence, pathology, risk factors (including HPV) of head and neck tumours 
• Clinical work-up for oral cavity and pharyngo-laryngeal tumours, staging and follow up 
• "Organ preservation” approach
• Rationale for unconventional radiotherapy fractionation, hypoxic sensitisers, concomitant chemo, EGFR inhibitors, immunotherapy and new targeted agents
• Management of oral cavity tumours: medical oncology, surgery and radiotherapy (including brachytherapy)
• Management of nasopharyngeal carcinoma
• Management of oropharyngeal tumours: medical oncology, surgery and radiotherapy (including brachytherapy)
• Management of hypopharyngeal and laryngeal tumours: surgery, radiotherapy and medical oncology chemotherapy approach
• Management of nasal cavity and para-nasal sinus tumours: surgery, radiotherapy and medical oncology chemotherapy approach
• Management of the neck nodes
• Concepts behind selection and delineation of target volumes in radiotherapy 
• Morbidity (acute and late) of treatment
• Supportive care during and after treatment
• Metastatic disease
• Management of recurrent tumours 
• Second primary tumours

Prerequisites

Before commencing this course, participants should have a medical degree with strong interest in head and neck tumour management from the radiation oncology, medical oncology or head and neck surgery point of view.

TEACHING METHODS

• 20 lecture hours
• 5 case discussion hours
• Delineation exercises

Methods of assessment

• MCQ 
• Delineation exercise/s 
• Evaluation form.

Scientific Progamme to follow

Key words

• Multidisciplinary head and neck oncology
• Evidence based medicine

Accreditation

Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

To follow

Membership

ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2026 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.

Fees

* Members with specialty RadiationTherapist (RTT) may register at the In-Training fee

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

Participants are strongly advised to take out their own personal insurance policy. ESTRO does not accept liability for individual medical, travel or personal accidents or incidents. Participants are strongly advised to take insurance policies to cover flight and accommodation cancellation penalties. ESTRO will not refund any travel or accommodation expenses.

For any cancellation made by the course participant, ESTRO School Events Cancellation Policy will be followed and all stated penalty fees will be applied.

Reduced fees

Members from emerging countries may register at a preferential rate of 350 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here.

Additionally, all specialties from the following countries can benefit from this preferential rate: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Hungary, Macedonia, Moldova, Montenegro, Romania, Russian Federation, Serbia, Turkey, Ukraine.  In addition, medical physicists from Cyprus can email education@estro.org to apply for this fee.

The preferential rate of 350 Euro is granted automatically when you click on the  BOOK NOW  button and the three conditions below are met:

1. Only ESTRO members for 2026 are eligible (please make sure your 2026 membership is in order before you click on the BOOK NOW  button)
2. Only one course per person per year can be subsidized by ESTRO
3. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  

 Please note:

• We can only guarantee a certain number of reduced fees per course
• Application deadlines are the same as early registration fees